Harvard Thoracic Pathology 2024
50.00 $
Video Lectures + PDFs
This course, co-directed by Dr. Mino-Kenudson at Massachusetts General Hospital, Boston, and Dr. William Travis at Memorial Sloan Kettering Cancer Center, New York, presents a broad over-view of thoracic pathology with clinical, radiologic, and molecular correlation. It has been sponsored by Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center and endorsed by the Pulmonary Pathology Society. The course is designed to provide updates on thoracic pathology and aids in diagnosis based on conventional morphologic analysis as well as immunohistochemistry and molecular analyses. The program features conventional didactic lectures with frequent and extensive discussion periods and case-based presentations, including some multidisciplinary sessions, in a virtual format. The faculty consist of thoracic and molecular pathologists, thoracic radiologists, surgeons, and oncologists, and pulmonologists from Massachusetts General Hospital, Brigham and Women’s Hospital, Memorial Sloan Kettering Cancer Center, and other academic medical centers, who have known expertise in the specific subject matter areas. The presentations will illustrate the importance of a multidisciplinary approach to solve difficult problems in thoracic diseases. The target audience for this course includes pathologists, pulmonologists, thoracic surgeons, and radiologists, including physicians in training, in both academic and community settings.
Who Should Attend
- Specialty Physicians
- Physician Assistants
- Nurse Practitioners
- Industry
Learning Objectives
Upon completion of this activity, participants will be able to:
- Evaluate individual tests and their tissue requirements for clinical management of advanced lung cancer patients.
- Apply the updated staging guidelines for lung cancer.
- Analyze current diagnostic criteria for Mesothelioma, including a clinicopathological staging system.
- Determine when to apply the international guidelines for the care of patients with Interstitial Lung Disease.
Friday, September 13, 2024
Opening Remarks
Mari Mino-Kenudson, MD
Updates in Classification and Diagnosis in Lung Cancer
William D. Travis, MD
Therapeutic Relevant Molecular Subsets of Lung Cancer
A. John Iafrate, MD, PhD
Current Update in Thoracic Oncology: Implications for Pathologists
Zofia Piotrowska, MD
What Does a Thoracic Surgeon Want to Know from Pathologists?
Hugh Auchincloss, MD, MPH
Q&A Session
Break
Immunohistochemistry for Lung Cancer Diagnosis
Natasha Rekhtman, MD, PhD
Minimally Invasive Endobronchial Techniques, Including Ion Robot Bronchoscopy
Colleen Keyes, MD
Diagnosis of Lung Cancer in Small Biopsies and Cytology
Paul VanderLaan, MD, PhD
Immunohistochemistry for Predictive Markers in Lung Cancer
Mari Mino-Kenudson, MD
Q&A Session
Lunch Break
Staging of Lung Cancer
Natasha Rekhtman, MD, PhD
Radiologic Pathologic Correlations in Thoracic Neoplasia
Subba Digumarthy, MD
Variants of Lung Adenocarcinoma and Squamous Cell Carcinoma
Mari Mino-Kenudson, MD
Q&A Session
Break
Neuroendocrine Tumors of the Lung
Natasha Rekhtman, MD, PhD
Update on IASLC/AMP/CAP Molecular Guidelines on Lung Tumor
Lynette Sholl, MD
Tumor Board Discussion
Ibiayi Dagogo-Jack, MD; Mari Mino-Kenudson, MD; Melissa Price, MD; Michael Lanuti, MD
Q&A Session
Saturday, September 14, 2024
Pathology of Interstitial Lung Disease
William D. Travis, MD
Radiology of Interstitial Lung Disease
Amita Sharma, MD
Clinical Profile of Interstitial Lung Disease
Barry Shea, MD
Pathology of Interstitial Lung Disease II
William D. Travis, MD
Q&A Session
Break
The Spectrum of Hypersensitivity Reactions in the Lung
Lida Hariri, MD, PhD
Lung Manifestations of Systemic Disorders (including IgG4-Related Diseases and Vaculitis)
Mary Beth Beasley, MD
The Pathologist’s Role in Multidisciplinary Discussion for Interstitial Lung Disease
Lida Hariri, MD, PhD
Multidisciplinary Approach to Interstitial Lung Disease
Lida Hariri, MD, PhD; Amita Sharma, MD; Barry Shea, MD
Q&A Session
Lunch Break
Diagnostic Approach to Acute Lung Injury
Mary Beth Beasley, MD
COVID-Related Lung Disease
Mari Mino-Kenudson, MD
Pathology of Lung Transplantation
Marina Vivero, MD
Q&A Session
Break
Tumor-Like Lesions of the Lung
Mari Garcia Moliner, MD
Pulmonary Infection
Angela Shih, MD
Pitfalls in Intraoperative Consultation and QA Issues of Thoracic Diseases
Angela Shih, MD
Q&A Session
Sunday, September 15, 2024
Malignant Mesothelioma
Lucian Chirieac, MD
Unusual Mediastinal and Thoracic Epithelial Tumos (NUT, SMARCA4, Germ Cell, Other)
Yin (Rex) Hung, MD, PhD
Thymomas and Their Differential Diagnoses
Yin (Rex) Hung, MD, PhD
Pulmonary and Mediastinal Lymphomas
Aliyah Sohani, MD
Q&A Session
Break
Tumors of Trachea and Salivary Gland-Type Tumors
Michiya Nishino, MD, PhD
Thoracic Soft Tissue Tumors
Yin (Rex) Hung, MD, PhD
Mystery Cases
Angela Shih, MD; Igor Odintsov, MD
Q&A Session
Closing Remarks and Adjourn
Mari Mino-Kenudson, MD
Related products
